Chemerin as an independent predictor of cardiovascular event risk.
Currently, coronary artery disease (CAD) is considered a major ailment in humans with widespread prevalence. CAD also accounts for high mortality rates around the world that involves several known risk factors. Chemerin is a novel adipokinine that is associated with inflammation and adipogenesis. Furthermore, experimental and clinical data indicate that localized as well as circulating chemerin expression and activation are elevated in numerous metabolic and inflammatory diseases including psoriasis, obesity, type 2 diabetes, metabolic syndrome and cardiovascular disease. Chemerin is accepted as being a strong marker because the serum chemerin levels are increased in a CAD condition. However, the chimeric characteristics of chemerin have not been fully investigated. Although chemerin is known to be responsible for CAD development among other factors, authors still investigate it at the marker level. This review focuses on chemerin expression, processing, biological function and relevance to human diseases, and on the role of chemerin in the maintenance of a cardiovascular disease.
Departmant of Cardiology, Aksaray State Hospital, Zafer mah.Nevşehir cad. no:117, Aksaray/Merkez, Turkey.
Sinan
S
İnci
Departmant of Cardiology, Şişli Etfal Education and Tracking Hospital, İstanbul, Turkey.
Gökhan
G
Aksan
Departmant of Cardiology, Aksaray State Hospital, Aksaray, Turkey.
Pınar
P
Doğan
cardiovascular disease; chemerin; marker